Dompe Announces Results of Phase 2 Study Evaluating the Effica...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
MILAN, June 13, 2022, /PRNewswire-AsiaNet/ -- - In hospitalized patients with COVID-19 Pneumonia, the rates of clinical events among those treated with Reparixin (n=36) were statistically significantly lower than standard of care (n=19).- The study is the first evaluation of the efficacy an...
Authors: LATEST ASIANET NEWS RELEASES